2.85 USD
▲-0.04+1.42%
盘后 2.85 +1.42%
2026-08-03
市值
$34.64M
市盈率
—
EPS
-2.51
股息率
—
52 周区间
2.81 – 8.63
成交量
6.99K
Beta
1.97
目标价
—
52W 低 2.8152W 高 8.63
价格走势
公司简介
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.